{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:20:07Z","timestamp":1786994407475,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006010","name":"Bayer Schering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.msard.2018.07.004","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T14:08:25Z","timestamp":1530713305000},"page":"151-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Health utilities of patients with multiple sclerosis and neuromyelitis optica spectrum disorders in Thailand"],"prefix":"10.1016","volume":"24","author":[{"given":"Sasitorn","family":"Siritho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montarat","family":"Thavorncharoensap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chalakorn","family":"Chanatittarat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pakamas","family":"Pasogpakdee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metha","family":"Apiwattanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naraporn","family":"Prayoonwiwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwaporn","family":"Chankrachang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthorn","family":"Riewpaiboon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9457-9823","authenticated-orcid":false,"given":"Usa","family":"Chaikledkaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2018.07.004_bib0001","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.msard.2013.06.009","article-title":"NMO spectrum disorders comprise the major portion of CNS inflammatory diseases in Thai patients: a cross sectional study","volume":"3","author":"Apiwattanakul","year":"2014","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2018.07.004_bib0002","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1468-1331.2010.03252.x","article-title":"Evaluation of health-related qulaity of life, fatigue and depression in neuromyelitits optica","volume":"18","author":"Chanson","year":"2011","journal-title":"Eur. J. Neurol."},{"issue":"17","key":"10.1016\/j.msard.2018.07.004_bib0003","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.4103\/0366-6999.189046","article-title":"Clinical features of patients with multiple sclerosis and neuromyelitis optica spectrum disorders","volume":"129","author":"Chen","year":"2016","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.msard.2018.07.004_bib0004","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/smi.2432","article-title":"Impact of depression, fatigue and disability on quality of life in Chinese patients with multiple sclerosis","volume":"29","author":"Chen","year":"2012","journal-title":"Stress Health"},{"issue":"9","key":"10.1016\/j.msard.2018.07.004_bib0005","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1001\/archneur.60.9.1336","article-title":"Neuromyelitis optica","volume":"60","author":"De Seze","year":"2003","journal-title":"Arch. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2018.07.004_bib0006","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1177\/1352458512474860","article-title":"Relating health-related quality of life to disability progression in multiple sclerosis, using the 5-level EQ-5D","volume":"19","author":"Fogarty","year":"2013","journal-title":"Mult. Scler. Int."},{"issue":"4","key":"10.1016\/j.msard.2018.07.004_bib0007","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jval.2016.01.002","article-title":"Health utilities for multiple sclerosis","volume":"19","author":"Hawton","year":"2016","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.msard.2018.07.004_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065640","article-title":"How people with multiple sclerosis rate their quality of life: An EQ-5D surey via the UK MS register","volume":"8","author":"Jones","year":"2013","journal-title":"Plos ONE"},{"issue":"1","key":"10.1016\/j.msard.2018.07.004_bib0009","first-page":"107","article-title":"Quality of life in patients with multiple sclerosis","volume":"52","author":"Kes","year":"2013","journal-title":"Acta Clin. Croat."},{"key":"10.1016\/j.msard.2018.07.004_bib0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11136-010-9725-2","article-title":"Impact and characteristics of quality of life in Japanese patients with multiple sclerosis","volume":"20","author":"Kikuchi","year":"2011","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.msard.2018.07.004_bib0011","series-title":"Quality of Life and Pharmacoeconomics in Clinical Trials","first-page":"191","article-title":"The EuroQoL instrument: an index of health-related quality of life","author":"Kind","year":"1996"},{"key":"10.1016\/j.msard.2018.07.004_bib0012","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pathophys.2010.04.008","article-title":"Neuromyelitis optica and opticospinal multiple sclerosis: mechanisms and pathogenesis","volume":"18","author":"Kira","year":"2011","journal-title":"Pathophysiology"},{"key":"10.1016\/j.msard.2018.07.004_bib0013","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/jnnp.2006.090365","article-title":"Costs and quality of life of patients with multiple sclerosis in Europe","volume":"77","author":"Kobelt","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"66","key":"10.1016\/j.msard.2018.07.004_bib0014","article-title":"Estimating a minimal clinically important difference for the euroqol 5-dimenstion health status index in persons with multiple sclerosis","volume":"12","author":"Kohn","year":"2014","journal-title":"Health Qual. Life Outcomes"},{"issue":"11","key":"10.1016\/j.msard.2018.07.004_bib0015","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"71","key":"10.1016\/j.msard.2018.07.004_bib0016","article-title":"Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis?","volume":"11","author":"Kuspina R","year":"2013","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.msard.2018.07.004_bib0017","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s40273-014-0167-5","article-title":"A review of the psychometric properties of generic utility measures in multiple sclerosis","volume":"32","author":"Kuspinar","year":"2014","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.msard.2018.07.004_bib0018","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3111\/13696990903543085","article-title":"The impact of increasing neurological disability of multiple sclerosis on health utilities: a systematic review of the literature","volume":"13","author":"Naci","year":"2010","journal-title":"J. Med. Econ."},{"key":"10.1016\/j.msard.2018.07.004_bib0019","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"New Eng. J. Med."},{"issue":"2","key":"10.1016\/j.msard.2018.07.004_bib0020","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2018.07.004_bib0021","series-title":"Pan Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS)","article-title":"Prevalence of idiopathic inflammatory demyelinating central nervous system disorder in Thailand","author":"Prayoonwiwat","year":"2013"},{"issue":"Suppl1","key":"10.1016\/j.msard.2018.07.004_bib0022","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.jval.2011.11.005","article-title":"Health utility measured with EQ-5D in Thai patients undergoing peritoneal dialysis","volume":"15","author":"Sakthong","year":"2012","journal-title":"Value Health"},{"issue":"5","key":"10.1016\/j.msard.2018.07.004_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177230","article-title":"Fatigue in patients with neuromyelitis optica spectrum disorder and its impact on quality of life","volume":"12","author":"Seok","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2018.07.004_bib0024","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jneuroim.2016.02.011","article-title":"Factors that impact health-related quality of life in neuromyelitis optica spectrum discorder: anxiety, disability, fatigue and depression","volume":"293","author":"Shi","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"Suppl 5","key":"10.1016\/j.msard.2018.07.004_bib0025","first-page":"S43","article-title":"Measurement of utility","volume":"97","author":"Thavorncharoensap","year":"2014","journal-title":"J. Med. Assoc. Thai"},{"issue":"8","key":"10.1016\/j.msard.2018.07.004_bib0026","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jval.2011.06.005","article-title":"Estimating population-based values for EQ-5D health states in Thailand","volume":"14","author":"Tongsiri","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.msard.2018.07.004_bib0027","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2018.07.004_bib0028","doi-asserted-by":"crossref","unstructured":"Wingerchuk D.M., et\u00a0al., International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. 85, 2015. 2: p. 177\u201389.","DOI":"10.1212\/WNL.0000000000001729"},{"issue":"3","key":"10.1016\/j.msard.2018.07.004_bib0029","first-page":"3","article-title":"Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases","volume":"11","author":"Yokote","year":"2016","journal-title":"Neural. Regen. Res,"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034818302049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034818302049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:41:39Z","timestamp":1761900099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034818302049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":29,"alternative-id":["S2211034818302049"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2018.07.004","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health utilities of patients with multiple sclerosis and neuromyelitis optica spectrum disorders in Thailand","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2018.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}